- decreased bone mineral density / IMPC
- increased leukocyte cell number / IMPC
- increased monocyte cell number / IMPC
- tremors / IMPC
- decreased body length / IMPC
- male infertility / IMPC
- female infertility / IMPC
- increased hematocrit / IMPC
- increased circulating serum albumin level / IMPC
- increased circulating alkaline phosphatase level / IMPC
- thrombocytopenia / IMPC
- increased circulating glycerol level / IMPC
- abnormal bone structure / IMPC
- increased lean body mass / IMPC
- decreased lean body mass / IMPC
- abnormal auditory brainstem response / IMPC
- increased B cell number / IMPC
- increased circulating cholesterol level / IMPC
- increased circulating aspartate transaminase level / IMPC
- increased circulating bilirubin level / IMPC
- decreased circulating glucose level / IMPC
- increased mean corpuscular hemoglobin / IMPC
- increased hemoglobin content / IMPC
- decreased NK T cell number / IMPC
- increased mature B cell number / IMPC
- decreased gamma-delta T cell number / IMPC
- increased circulating iron level / IMPC
- increased total body fat amount / IMPC
- decreased total body fat amount / IMPC
- decreased red blood cell distribution width / IMPC
- decreased circulating fructosamine level / IMPC
- decreased bone mineral content / IMPC
- decreased effector memory CD8-positive, alpha-beta T cell number / IMPC
- increased KLRG1-positive NK cell number / IMPC
- increased Ly6C high monocyte number / IMPC
- increased Ly6C low monocyte number / IMPC
- decreased memory-marker CD4-negative NK T cell number / IMPC
- decreased CD4-positive NK T cell number / IMPC
- decreased memory-marker CD4-positive NK T cell number / IMPC
C57BL/6N-Atm1Brd Clpptm1a(EUCOMM)Wtsi/WtsiH
Status | Available to order |
EMMA ID | EM:09701 |
Citation information | RRID:IMSR_EM:09701 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | C57BL/6N-Atm1Brd Clpptm1a(EUCOMM)Wtsi/WtsiH |
Alternative name | EPD0665_3_D05 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Clpptm1a(EUCOMM)Wtsi |
Gene/Transgene symbol | Clpp |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from EUCOMM ES clone EPD0665_3_D05. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Perrault syndrome / Orphanet_2855
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- thrombocytopenia / IMPC
- increased circulating bilirubin level / IMPC
- decreased lean body mass / IMPC
- increased leukocyte cell number / IMPC
- increased circulating cholesterol level / IMPC
- increased mean corpuscular hemoglobin / IMPC
- increased monocyte cell number / IMPC
- increased Ly6C low monocyte number / IMPC
- decreased bone mineral content / IMPC
- decreased circulating fructosamine level / IMPC
- increased lean body mass / IMPC
- increased KLRG1-positive NK cell number / IMPC
- increased circulating glycerol level / IMPC
- decreased total body fat amount / IMPC
- decreased NK T cell number / IMPC
- decreased memory-marker CD4-positive NK T cell number / IMPC
- decreased body length / IMPC
- increased hemoglobin content / IMPC
- increased total body fat amount / IMPC
- increased mature B cell number / IMPC
- decreased bone mineral density / IMPC
- decreased circulating glucose level / IMPC
- increased circulating serum albumin level / IMPC
- increased B cell number / IMPC
- abnormal bone structure / IMPC
- tremors / IMPC
- increased circulating iron level / IMPC
- decreased effector memory CD8-positive, alpha-beta T cell number / IMPC
- abnormal auditory brainstem response / IMPC
- increased Ly6C high monocyte number / IMPC
- female infertility / IMPC
- decreased CD4-positive NK T cell number / IMPC
- decreased red blood cell distribution width / IMPC
- increased circulating aspartate transaminase level / IMPC
- increased hematocrit / IMPC
- decreased memory-marker CD4-negative NK T cell number / IMPC
- increased circulating alkaline phosphatase level / IMPC
- male infertility / IMPC
- decreased gamma-delta T cell number / IMPC
MGI phenotypes (gene matching)
- decreased cell proliferation / MGI
- small ovary / MGI
- small testis / MGI
- arrest of spermatogenesis / MGI
- dermatitis / MGI
- decreased body length / MGI
- hypoactivity / MGI
- decreased startle reflex / MGI
- abnormal T cell activation / MGI
- male infertility / MGI
- female infertility / MGI
- abnormal oogenesis / MGI
- premature death / MGI
- decreased corpora lutea number / MGI
- decreased vertical activity / MGI
- azoospermia / MGI
- early cellular replicative senescence / MGI
- abnormal granulosa cell morphology / MGI
- decreased susceptibility to weight gain / MGI
- abnormal cellular respiration / MGI
- preweaning lethality, incomplete penetrance / MGI
- increased mitochondria size / MGI
- disorganized mitochondrial cristae / MGI
- abnormal mitochondrial chromosome morphology / MGI
- abnormal seminiferous tubule epithelium morphology / MGI
- increased embryonic tissue cell apoptosis / MGI
- increased granulosa cell apoptosis / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).